76 related articles for article (PubMed ID: 21270758)
1. Immunohistochemical analysis of beta-defensin-2 expression in human lung tumors.
Shestakova T; Zhuravel E; Bolgova L; Zaitsev S; Efanova O; Soldatkina M; Pogrebnoy P
Exp Oncol; 2010 Dec; 32(4):273-6. PubMed ID: 21270758
[TBL] [Abstract][Full Text] [Related]
2. Expression of human beta-defensins-1, 2 and 4 mRNA in human lung tumor tissue: a pilot study.
Shestakova T; Zhuravel E; Bolgova L; Alekseenko O; Soldatkina M; Pogrebnoy P
Exp Oncol; 2008 Jun; 30(2):153-6. PubMed ID: 18566581
[TBL] [Abstract][Full Text] [Related]
3. A technique to improve diagnostic information from fine-needle aspirations: immunohistochemistry on cytoscrape.
Skov BG; Kiss K; Ramsted J; Linnemann D
Cancer; 2009 Apr; 117(2):120-7. PubMed ID: 19365834
[TBL] [Abstract][Full Text] [Related]
4. Defective expression of transforming growth factor beta type II receptor (TGFBR2) in the large cell variant of non-small cell lung carcinoma.
Xu JB; Bao Y; Liu X; Liu Y; Huang S; Wang JC
Lung Cancer; 2007 Oct; 58(1):36-43. PubMed ID: 17566598
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum beta-defensins concentrations in patients with lung cancer.
Arimura Y; Ashitani J; Yanagi S; Tokojima M; Abe K; Mukae H; Nakazato M
Anticancer Res; 2004; 24(6):4051-7. PubMed ID: 15736451
[TBL] [Abstract][Full Text] [Related]
6. Combined small cell lung carcinomas: genotypic and immunophenotypic analysis of the separate morphologic components.
Wagner PL; Kitabayashi N; Chen YT; Saqi A
Am J Clin Pathol; 2009 Mar; 131(3):376-82. PubMed ID: 19228643
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of p53 protein and prognosis of surgically resected non-small-cell lung cancer.
Quantin X; Pujol JL; Lehmann M; Simony J; Serre I; Michel FB
Cancer Detect Prev; 1997; 21(5):418-25. PubMed ID: 9307845
[TBL] [Abstract][Full Text] [Related]
8. Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer.
Abe K; Miki Y; Ono K; Mori M; Kakinuma H; Kou Y; Kudo N; Koguchi M; Niikawa H; Suzuki S; Evans DB; Sugawara S; Suzuki T; Sasano H
Hum Pathol; 2010 Feb; 41(2):190-8. PubMed ID: 19800101
[TBL] [Abstract][Full Text] [Related]
9. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
[TBL] [Abstract][Full Text] [Related]
10. Expression of the estrogen receptor beta in 37 surgically treated pulmonary sclerosing hemangiomas in comparison with non-small cell lung carcinomas.
Wu CT; Chang YL; Lee YC
Hum Pathol; 2005 Oct; 36(10):1108-12. PubMed ID: 16226111
[TBL] [Abstract][Full Text] [Related]
11. A pharmacokinetic and dose escalation study of pegfilgrastim (KRN125) in lung cancer patients with chemotherapy-induced neutropenia.
Yamamoto N; Sekine I; Nakagawa K; Takada M; Fukuoka M; Tanigawara Y; Saijo N
Jpn J Clin Oncol; 2009 Jul; 39(7):425-30. PubMed ID: 19395467
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and prognostic importance of the expression of epidermal growth factor receptors in non-small-cell lung carcinoma].
Kostyleva OI; Gershteĭn ES; Dykhno AIu; Polotskiĭ BE; Vasil'ev AV; Kushlinskiĭ NE
Biull Eksp Biol Med; 1999 Apr; 127(4):446-9. PubMed ID: 10367133
[No Abstract] [Full Text] [Related]
14. [Expression of SKP2 protein in lung carcinoma and its implication for prognosis].
Zhao J; Yang CL; Zhao SY
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):289-92. PubMed ID: 17760257
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin expression and prognostic significance in non-small cell lung cancer.
Donati V; Boldrini L; Dell'Omodarme M; Prati MC; Faviana P; Camacci T; Lucchi M; Mussi A; Santoro M; Basolo F; Fontanini G
Clin Cancer Res; 2005 Sep; 11(18):6459-65. PubMed ID: 16166420
[TBL] [Abstract][Full Text] [Related]
16. Abnormal beta-catenin and reduced axin expression are associated with poor differentiation and progression in non-small cell lung cancer.
Xu HT; Wang L; Lin D; Liu Y; Liu N; Yuan XM; Wang EH
Am J Clin Pathol; 2006 Apr; 125(4):534-41. PubMed ID: 16627264
[TBL] [Abstract][Full Text] [Related]
17. Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients.
Marchetti A; Tinari N; Buttitta F; Chella A; Angeletti CA; Sacco R; Mucilli F; Ullrich A; Iacobelli S
Cancer Res; 2002 May; 62(9):2535-9. PubMed ID: 11980646
[TBL] [Abstract][Full Text] [Related]
18. Expression of nestin in lymph node metastasis and lymphangiogenesis in non-small cell lung cancer patients.
Chen Z; Wang T; Luo H; Lai Y; Yang X; Li F; Lei Y; Su C; Zhang X; Lahn BT; Xiang AP
Hum Pathol; 2010 May; 41(5):737-44. PubMed ID: 20132963
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
20. [The role of Smad4 and MAPK proteins in signal transduction pathway in non-small cell lung cancer].
Tong XD; Liu HX; Zhao HR; Xu SG; Li Y; Han LB; Zhang L
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):741-5. PubMed ID: 17366784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
